Acceptability of In Utero Hematopoietic Cell Transplantation for Sickle Cell Disease-Reference-Cited by-同舟云学术

Acceptability of In Utero Hematopoietic Cell Transplantation for Sickle Cell Disease

Published:2017-05-10 Issue:8 Volume:37 Page:914-921
ISSN:0272-989X
Container-title:Medical Decision Making
language:en
Short-container-title:Med Decis Making

Author:

Antiel Ryan M.¹²³⁴⁵,Halpern Scott D.¹²³⁴⁵,Stevens Evelyn M.¹²³⁴⁵,Vrecenak Jesse D.¹²³⁴⁵,Patterson Chavis A.¹²³⁴⁵,Tchume-Johnson Trudy¹²³⁴⁵,Smith-Whitley Kim¹²³⁴⁵,Peranteau William H.¹²³⁴⁵,Flake Alan W.¹²³⁴⁵,Barakat Lamia P.¹²³⁴⁵

Affiliation:

1. The Center for Fetal Research, The Children’s Hospital of Philadelphia, Philadelphia, PA, USA (RMA, JDV, WHP, AWF)

2. Department of Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA (SDH)

3. Division of Oncology, The Children’s Hospital of Philadelphia, Philadelphia, PA, USA (EMS, TT, LPB)

4. Department of Medical Ethics and Health Policy, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA, USA (RMA, SDH)

5. Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA, USA (SDH)

Publisher

SAGE Publications

Subject

Health Policy

Link

http://journals.sagepub.com/doi/pdf/10.1177/0272989X17707214

Reference35 articles.

1. Management of sickle cell disease from childhood through adulthood

2. Hematopoietic Stem Cell Transplantation in Thalassemia and Sickle Cell Anemia

3. Stable long-term mixed chimerism achieved in a canine model of allogeneic in utero hematopoietic cell transplantation

4. In utero hematopoietic cell transplantation—recent progress and the potential for clinical application

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving Development of Drug Treatments for Pregnant Women and the Fetus;Therapeutic Innovation & Regulatory Science;2022-07-25

2. Ethical and Regulatory Considerations of Placental Therapeutics;Clinical Therapeutics;2021-02

3. In Utero Hematopoietic Cell Transplantation Does Not Alter the Germ Line;Journal of Surgical Research;2021-01

4. Fetal and Maternal Safety Considerations for In Utero Therapy Clinical Trials: iFeTiS Consensus Statement;Molecular Therapy;2020-11

5. Embryonic intraventricular transplantation of neural stem cells augments inflammation-induced prenatal brain injury;Journal of Chemical Neuroanatomy;2018-12